SCHEMBL38656248

SCHEMBL38656248

CC(C)c1ccc(NC(=O)[C@H]2CCCN2C(=O)OC(C)(C)C)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.74
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
LMNA P02545 2/20 0.59
NPSR1 Q6W5P4 1/20 0.59
ALDH1A1 P00352 4/20 0.56
L3MBTL1 Q9Y468 3/20 0.56
MAPK1 P28482 2/20 0.56
HTT P42858 2/20 0.56
MAPT P10636 1/20 0.56
RAB9A P51151 1/20 0.56
POLB P06746 1/20 0.55
JAK2 O60674 1/20 0.54
USP30 Q70CQ3 1/20 0.50
EP300 Q09472 1/20 0.50
CREBBP Q92793 1/20 0.50
PTPN2 P17706 1/20 0.50
PTPN1 P18031 1/20 0.50
PTPN6 P29350 1/20 0.50
PABPC1 P11940 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38658670 1.00 NPC1 (0.74) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL78329 0.88 NPC1 (0.77) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL17474788 0.88 NPC1 (0.80) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL17474759 0.88 NPC1 (0.80) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL23373363 0.87 NPC1 (0.79) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL1752676 0.86 NPC1 (0.77) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL10092397 0.86 NPC1 (0.77) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL31188356 0.86 NPC1 (0.77) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL3833819 0.86 NPC1 (0.77) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL2525285 0.86 NPC1 (0.77) NPC1MEN1KMT2ALMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026102082-A1 ALKYLPHENYL SUBSTITUTED COMPOUNDS, COMPOSITIONS AND METHODS OF USE DEEP APPLE THERAPEUTICS, INC. (US) 2026-05-15 WO disclosed
US-20260132119-A1 Alkylphenyl Substituted Compounds, Compositions and Methods of Use DEEP APPLE THERAPEUTICS, INC. (US) 2026-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132119-A1 Alkylphenyl Substituted Compounds, Compositions and Methods of Use GIPR, MC2R, GRPR NPC1 211/4885MEN1 1814/4885KMT2A 4321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.